{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-301902","form_type":"8-K","ticker":"ERAS","cik":"0001761918","company_name":"Erasca, Inc.","filed_at":"2022-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.026414+00:00","generated_at":"2026-06-21T06:52:04.383041+00:00","sec_items":["3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Erasca (ERAS) prices $100M public offering and issues $80M stock to Novartis under license","bullets":["Underwritten offering of 15,384,616 shares at $6.50/share; net proceeds ~$94.7M; expected close Dec 13, 2022.","Private placement to Novartis of 12,307,692 shares at $6.50/share as partial consideration for exclusive license agreement.","J.P. Morgan and Goldman Sachs are joint book-running managers for the public offering.","Proceeds to fund R&D of RAS/MAPK pathway programs and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-301902","json":"https://secwatch.observer/filing/0001193125-22-301902.json","markdown":"https://secwatch.observer/filing/0001193125-22-301902.md","text":"https://secwatch.observer/filing/0001193125-22-301902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761918/000119312522301902/0001193125-22-301902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761918/000119312522301902/d435484d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:52:04.383041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}